Mogrify

Series-A
mogrify.co.uk Biotech & Healthcare
Total Funding $3.7M
Latest Round Undisclosed Series-A
Last Announced Oct 2, 2023
Investors Undisclosed
Decision Makers 5 Available

About Mogrify

Mogrify is transforming the lives of patients with degenerative diseases through a novel class of in vivo reprogramming therapies.

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-A
Global Headquarters Undisclosed
Tracked Since Nov 8, 2026

Web & Domain Identity

Official Website mogrify.co.uk
Domain Registered Date Undisclosed

Social & Network Presence

X / Twitter Profile @Mogrify_UK (810 followers)
LinkedIn Corporate Company Profile

Company Milestones & Timeline

2 Events
  1. Capital Raise

    Raised undisclosed · Series-A

    fundraisingfox.com

  2. Capital Raise

    Raised $3,700,000 · Seed

    startupintros.com

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for Mogrify.

Funding History

2 Rounds
Series-A equity · Oct 2, 2023
Seed equity · Feb 20, 2019

Founders & Leadership

3

J. Gough

Co-founder

Work email & phone locked Unlock →

J. Polo

Co-founder

Work email & phone locked Unlock →

O. Rackham

Co-founder

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

Recently funded startups
New SaaS launches
Never pay twice for contacts